Transient Ischemic Attack
📧 Sign up to get email alerts when something new happens for Transient Ischemic Attack.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: PFx Closure System in Subjects With Cryptogenic Stroke, TIA, Migraine or Decompression Illness [NA]
The PFx Closure System trial for patients with patent foramen ovale–related conditions (ischemic stroke, TIA, migraine, and decompression il…
-
FDA approval · 2007-10-22FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approves a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2007-05-11FDA Approved: PRAVASTATIN SODIUM — Original Application (CIPLA USA INC.)
FDA approved a generic pravastatin sodium product (Pravastatin Sodium) from Cipla USA Inc. through an Original Application (ANDA). This mark…
-
CLINICAL_TRIALS research · 2007-03-22Clinical Trial Update: ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial [Phase 4]
Clinical trial update for the ESPRIT study (European/Australasian Stroke Prevention in Reversible Ischaemia Trial), a Phase 4 trial focused …
-
CLINICAL_TRIALS research · 2006-11-29Clinical Trial Update: Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism [NA]
This entry reports a clinical trial called Paradigm I evaluating the PFX Closure System to close a patent foramen ovale in people with crypt…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.